UCB Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
1 result(s) found, displaying 1 to 1
-
Prescription medicine decision summaryZilbrysq (zilucoplan) has been approved as an add-on to standard therapy for the treatment of generalised myasthenia gravis in adult patients who are anti-acetylcholine receptor antibody positive.